Fredun Pharmaceuticals Limited (FREDUN.BO)
INR 674.9
(0.16%)
INR 674.9
(0.16%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 3.48 Billion INR | 26.91% |
| 2022 | 2.74 Billion INR | 23.72% |
| 2021 | 2.21 Billion INR | 68.65% |
| 2020 | 1.31 Billion INR | 16.67% |
| 2019 | 1.12 Billion INR | 16.97% |
| 2018 | 963.43 Million INR | 62.08% |
| 2017 | 594.42 Million INR | 4.84% |
| 2016 | 566.96 Million INR | 33.97% |
| 2015 | 423.21 Million INR | 66.9% |
| 2014 | 253.57 Million INR | 32.6% |
| 2013 | 191.23 Million INR | 26.8% |
| 2012 | 150.81 Million INR | 29.18% |
| 2011 | 116.75 Million INR | 46.51% |
| 2010 | 79.68 Million INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 788.1 Million INR | -33.23% |
| 2023 FY | 3.48 Billion INR | 26.91% |
| 2023 Q4 | 1.18 Billion INR | 35.66% |
| 2023 Q3 | 870.08 Million INR | 6.78% |
| 2023 Q2 | 814.8 Million INR | 33.08% |
| 2023 Q1 | 612.27 Million INR | -68.87% |
| 2022 FY | 2.74 Billion INR | 23.72% |
| 2022 Q4 | 1.96 Billion INR | 153.33% |
| 2022 Q2 | 688.44 Million INR | 43.05% |
| 2022 Q1 | 481.25 Million INR | -30.7% |
| 2022 Q3 | 776.45 Million INR | 12.78% |
| 2021 Q1 | 448.19 Million INR | 3.47% |
| 2021 FY | 2.21 Billion INR | 68.65% |
| 2021 Q4 | 694.47 Million INR | 30.74% |
| 2021 Q3 | 531.19 Million INR | -2.27% |
| 2021 Q2 | 543.5 Million INR | 21.27% |
| 2020 Q4 | 433.15 Million INR | -3.95% |
| 2020 Q1 | 132.62 Million INR | -50.73% |
| 2020 FY | 1.31 Billion INR | 16.67% |
| 2020 Q2 | 320.68 Million INR | 141.79% |
| 2020 Q3 | 450.98 Million INR | 40.63% |
| 2019 Q1 | 282.16 Million INR | -11.83% |
| 2019 FY | 1.12 Billion INR | 16.97% |
| 2019 Q2 | 314.32 Million INR | 11.4% |
| 2019 Q3 | 262.29 Million INR | -16.55% |
| 2019 Q4 | 269.17 Million INR | 2.62% |
| 2018 Q4 | 320.02 Million INR | 21.89% |
| 2018 FY | 963.43 Million INR | 62.08% |
| 2018 Q3 | 262.55 Million INR | 20.23% |
| 2018 Q2 | 218.36 Million INR | 34.39% |
| 2018 Q1 | 162.49 Million INR | -19.58% |
| 2017 FY | 594.42 Million INR | 4.84% |
| 2017 Q1 | 91.49 Million INR | -47.29% |
| 2017 Q2 | 150.41 Million INR | 64.4% |
| 2017 Q3 | 136.7 Million INR | -9.11% |
| 2017 Q4 | 202.05 Million INR | 47.8% |
| 2016 FY | 566.96 Million INR | 33.97% |
| 2016 Q3 | 125.04 Million INR | 20.97% |
| 2016 Q2 | 103.36 Million INR | -37.35% |
| 2016 Q1 | 164.99 Million INR | 4.25% |
| 2016 Q4 | 173.56 Million INR | 38.81% |
| 2015 Q1 | 79.16 Million INR | 63.59% |
| 2015 FY | 423.21 Million INR | 66.9% |
| 2015 Q4 | 158.26 Million INR | 26.48% |
| 2015 Q3 | 125.13 Million INR | 106.32% |
| 2015 Q2 | 60.65 Million INR | -23.38% |
| 2014 Q2 | 70.44 Million INR | 30.21% |
| 2014 Q1 | 54.1 Million INR | -4.46% |
| 2014 FY | 253.57 Million INR | 32.6% |
| 2014 Q4 | 48.38 Million INR | -12.66% |
| 2014 Q3 | 55.4 Million INR | -21.36% |
| 2013 Q1 | 42.65 Million INR | 61.55% |
| 2013 FY | 191.23 Million INR | 26.8% |
| 2013 Q3 | 53.83 Million INR | -9.88% |
| 2013 Q2 | 59.73 Million INR | 40.03% |
| 2013 Q4 | 56.62 Million INR | 5.2% |
| 2012 Q4 | 26.4 Million INR | -44.39% |
| 2012 FY | 150.81 Million INR | 29.18% |
| 2012 Q3 | 47.48 Million INR | 26.95% |
| 2012 Q2 | 37.4 Million INR | -5.36% |
| 2012 Q1 | 39.52 Million INR | 0.0% |
| 2011 FY | 116.75 Million INR | 46.51% |
| 2010 FY | 79.68 Million INR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Add-Shop E-Retail Limited | 2.02 Billion INR | -72.282% |
| Cian Healthcare Limited | 616.95 Million INR | -464.314% |
| Chemo Pharma Laboratories Limited | 18.38 Million INR | -18840.055% |
| Colinz Laboratories Limited | 70.29 Million INR | -4852.716% |
| Denis Chem Lab Limited | 1.67 Billion INR | -107.456% |
| Emmessar Biotech & Nutrition Limited | 5.55 Million INR | -62608.231% |
| Evoq Remedies Limited | 63.09 Million INR | -5418.404% |
| Gujarat Themis Biosyn Limited | 1.69 Billion INR | -105.012% |
| Jenburkt Pharmaceuticals Limited | 1.41 Billion INR | -145.238% |
| MedPlus Health Services Limited | 56.24 Billion INR | 93.81% |
| OXYGENTA PHARMACEUTICAL LIMITE | 396.42 Million INR | -778.248% |
| PANJON LTD. | 125.52 Million INR | -2673.688% |
| PRAVEG LIMITED | 915.96 Million INR | -280.097% |
| Sanjivani Paranteral Limited. | 536.87 Million INR | -548.491% |
| Sastasundar Ventures Limited | 13.56 Billion INR | 74.326% |
| SHAMROCK INDUSTRIAL CO.LTD. | 1.11 Million INR | -311309.75% |
| SHELTER PHARMA LIMITED | 400.22 Million INR | -769.892% |
| BDH Industries Limited | 858.31 Million INR | -305.63% |
| DECIPHER LABS LIMITED | 362.75 Million INR | -859.761% |
| ANG Lifesciences India Limited | 1.46 Billion INR | -138.284% |
| Veerhealth Care Limited | 142.13 Million INR | -2349.492% |
| Zenith Healthcare Limited | 144.71 Million INR | -2305.772% |
| Zenlabs Ethica Limited | 585.63 Million INR | -494.497% |
| Zenotech Laboratories Limited | 368.08 Million INR | -845.848% |
| Crestchem Limited | 212.56 Million INR | -1537.904% |
| Norris Medicines Limited | 56.35 Million INR | -6077.785% |
| Shukra Pharmaceuticals Limited | 745.72 Million INR | -366.867% |
| Sunil Healthcare Limited | 901.91 Million INR | -286.017% |
| Ambalal Sarabhai Enterprises Limited | 1.74 Billion INR | -99.712% |
| Bacil Pharma Limited | - INR | -Infinity% |
| Patidar Buildcon Limited | 2.3 Million INR | -150747.53% |
| Phaarmasia Limited | 305.93 Million INR | -1038.014% |
| Shree Ganesh Remedies Limited | 1.25 Billion INR | -176.544% |
| SUDARSHAN PHARMA INDUSTRIES LI | 4.63 Billion INR | 24.892% |
| Trimurthi Limited | 42.23 Million INR | -8142.722% |
| Vista Pharmaceuticals Limited | 102.87 Million INR | -3284.165% |
| Vivanza Biosciences Limited | 278.89 Million INR | -1148.355% |
| Hindustan Bio Sciences Limited | 10.48 Million INR | -33090.804% |
| Anuh Pharma Limited | 6.47 Billion INR | 46.19% |
| Beryl Drugs Limited | 271.24 Million INR | -1183.539% |
| Bharat Immunologicals & Biologicals Corporation Limited | 446.09 Million INR | -680.46% |
| Deccan Health Care Limited | 597.28 Million INR | -482.894% |
| Godavari Drugs Limited | 1.56 Billion INR | -122.163% |
| Gujarat Terce Laboratories Limited | 479.74 Million INR | -625.708% |
| Ishita Drugs and Industries Limited | 151.87 Million INR | -2192.371% |
| Kerala Ayurveda Limited | 1.02 Billion INR | -240.208% |
| KIMIA BIOSCIENCES LIMITED | 1.04 Billion INR | -231.968% |
| Lactose (India) Limited | 1.13 Billion INR | -205.696% |
| Makers Laboratories Limited | 1.03 Billion INR | -235.529% |
| Medi-Caps Limited | 265.63 Million INR | -1210.656% |
| Mercury Laboratories Limited | 755.59 Million INR | -360.774% |
| Parmax Pharma Limited | 154.24 Million INR | -2157.186% |
| Roopa Industries Limited | 715.53 Million INR | -386.566% |
| Smruthi Organics Limited | 1.27 Billion INR | -172.757% |
| Source Natural Foods and Herbal Supplements Limited | 272.96 Million INR | -1175.447% |
| Syschem (India) Limited | 2.33 Billion INR | -49.082% |
| Vikram Thermo (India) Limited | 1.25 Billion INR | -177.611% |
| Bharat Parenterals Limited | 2.59 Billion INR | -34.211% |
| Trident Lifeline Limited | 446.28 Million INR | -680.119% |
| Concord Drugs Limited | 449.24 Million INR | -674.98% |
| Gennex Laboratories Limited | 867.14 Million INR | -301.497% |
| TIAAN CONSUMER LIMITED | - INR | -Infinity% |
| Vasundhara Rasayans Limited | 370.18 Million INR | -840.495% |
| Parnax Lab Limited | 1.88 Billion INR | -84.491% |
| Trinity League India Limited | 2.95 Million INR | -117919.017% |
| Sandu Pharmaceuticals Limited | 672.8 Million INR | -417.468% |
| Tyche Industries Limited | 696.83 Million INR | -399.623% |
| Kwality Pharmaceuticals Limited | 3.07 Billion INR | -13.342% |
| Transchem Limited | 4.09 Million INR | -84816.143% |
| Pharmaids Pharmaceuticals Limited | 151.12 Million INR | -2203.823% |
| Panchsheel Organics Limited | 1.05 Billion INR | -230.888% |
| Coral Laboratories Limited | 836.6 Million INR | -316.154% |
| KOBO BIOTECH LIMITED | - INR | -Infinity% |
| Natural Capsules Limited | 1.55 Billion INR | -124.01% |
| Auro Laboratories Limited | 526.99 Million INR | -560.643% |